- Investing Ideas
- /
- Capital Goods Healthcare Sector
Capital Goods Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Bioventus
Market Cap: US$459.9m
A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.
BVS
US$6.99
7D
6.9%
1Y
13.5%
Allergy Therapeutics
Market Cap: UK£343.2m
A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.
AGY
UK£0.072
7D
4.3%
1Y
111.8%
kneat.com
Market Cap: CA$637.2m
Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.
KSI
CA$6.59
7D
-0.5%
1Y
60.0%
Cross Country Healthcare
Market Cap: US$457.0m
Provides talent management services for healthcare clients in the United States.
CCRN
US$13.79
7D
-1.1%
1Y
-3.2%
Cullinan Therapeutics
Market Cap: US$455.0m
A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.
CGEM
US$7.90
7D
3.7%
1Y
-65.9%
PYC Therapeutics
Market Cap: AU$708.7m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.22
7D
-1.2%
1Y
15.7%
Tilray Brands
Market Cap: US$452.7m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
TLRY
US$0.45
7D
0.6%
1Y
-76.3%
Claritev
Market Cap: US$451.7m
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV
US$28.72
7D
14.7%
1Y
32.2%
Altimmune
Market Cap: US$446.1m
A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.
ALT
US$5.85
7D
1.6%
1Y
-24.0%
Septerna
Market Cap: US$444.2m
A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
SEPN
US$9.42
7D
40.0%
1Y
n/a
Personalis
Market Cap: US$443.4m
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$4.96
7D
-3.5%
1Y
242.1%
Sage Therapeutics
Market Cap: US$442.7m
A biopharmaceutical company, develops and commercializes brain health medicines.
SAGE
US$7.13
7D
7.9%
1Y
-40.8%
Verastem
Market Cap: US$441.2m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$8.03
7D
7.6%
1Y
-33.4%
Tectonic Therapeutic
Market Cap: US$437.1m
A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).
TECX
US$24.56
7D
21.6%
1Y
n/a
Oxford Biomedica
Market Cap: UK£325.9m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£3.08
7D
5.3%
1Y
-7.2%
SIGA Technologies
Market Cap: US$433.3m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.20
7D
4.4%
1Y
-18.0%
Paragon Care
Market Cap: AU$670.4m
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.
PGC
AU$0.41
7D
-3.6%
1Y
n/a
EyePoint Pharmaceuticals
Market Cap: US$427.3m
Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
EYPT
US$6.21
7D
5.1%
1Y
-46.4%
Tourmaline Bio
Market Cap: US$427.2m
Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.
TRML
US$16.20
7D
4.2%
1Y
15.5%
Maze Therapeutics
Market Cap: US$424.8m
A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
MAZE
US$10.11
7D
2.5%
1Y
n/a
Treace Medical Concepts
Market Cap: US$423.4m
A medical technology company, designs, manufactures, and markets medical devices in the United States.
TMCI
US$6.69
7D
-4.2%
1Y
34.6%
Surmodics
Market Cap: US$421.5m
Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.
SRDX
US$29.68
7D
6.7%
1Y
-14.9%
Northwest Biotherapeutics
Market Cap: US$420.4m
A biotechnology company, focuses on developing personalized immune therapies for cancer.
NWBO
US$0.29
7D
0.3%
1Y
-37.0%
PureTech Health
Market Cap: UK£310.8m
Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
PRTC
UK£1.29
7D
6.4%
1Y
-42.7%
Knight Therapeutics
Market Cap: CA$577.8m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.77
7D
-0.7%
1Y
-4.9%
MeiraGTx Holdings
Market Cap: US$413.9m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$5.50
7D
6.8%
1Y
0%
MBX Biosciences
Market Cap: US$413.1m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.
MBX
US$12.36
7D
20.4%
1Y
n/a
Organogenesis Holdings
Market Cap: US$409.7m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$3.26
7D
3.5%
1Y
17.7%
Vitalhub
Market Cap: CA$569.0m
Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.
VHI
CA$10.27
7D
-3.8%
1Y
45.7%
Myriad Genetics
Market Cap: US$408.3m
A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.
MYGN
US$4.45
7D
8.3%
1Y
-81.7%
Autolus Therapeutics
Market Cap: US$407.2m
A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.
AUTL
US$1.53
7D
20.5%
1Y
-60.5%
COMPASS Pathways
Market Cap: US$407.0m
Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.
CMPS
US$4.62
7D
18.5%
1Y
-41.3%
Celcuity
Market Cap: US$404.8m
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$10.65
7D
-1.6%
1Y
-35.5%
Fortrea Holdings
Market Cap: US$402.9m
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE
US$4.69
7D
-6.2%
1Y
-82.2%
Precigen
Market Cap: US$401.4m
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$1.41
7D
4.4%
1Y
1.4%
Standard BioTools
Market Cap: US$398.8m
Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.
LAB
US$1.05
7D
-7.9%
1Y
-59.3%